MedTrace Logo

Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients

NCT06357403 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1300

Last updated 2025-09-29

No results posted yet for this study

Summary

The goal of this observational study is to analyse the association between anti-factor Xa activity (antiXa) and the occurence of venous thromboembolism (VTE; either deep vein thrombosis and/or pulmonary embolism) in critically ill patients who are admitted to an intensive care unit. The main questions it aims to answer are:

* What is the association between antiXa and VTE?
* What is the association between antiXa and symptomatic, respectively incidental, VTE?
* How is pharmacological anticoagulation with enoxaparin related to measured antiXa?
* What is the association between antiXa and bleeding complications.
* What is the incidence of venous thromboembolism in patients treated at an intensive care unit?
* How is the occurence of VTE related to patient-centred outcomes such as mortality, quality of life, length of stay and days outside of the intensive care unit/hospital.

Conditions

Interventions

DIAGNOSTIC_TEST

Anti-factor Xa activity calibrated for enoxaparin

Anti-factor Xa activity calibrated for enoxaparin

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Eva Schaden, MD · Medical University of Vienna

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-04
Primary Completion
2027-05-31
Completion
2027-08-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06357403 on ClinicalTrials.gov